These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 17956194)

  • 1. Role of platinum agents in the management of advanced pancreatic cancer.
    Saif MW; Kim R
    Expert Opin Pharmacother; 2007 Nov; 8(16):2719-27. PubMed ID: 17956194
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Any progress in the management of advanced pancreatic cancer? Highlights from the 45th ASCO annual meeting. Orlando, FL, USA. May 29-June 2, 2009.
    Li J; Saif MW
    JOP; 2009 Jul; 10(4):361-5. PubMed ID: 19581735
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased survival using platinum analog combined with gemcitabine as compared to single-agent gemcitabine in advanced pancreatic cancer: pooled analysis of two randomized trials, the GERCOR/GISCAD intergroup study and a German multicenter study.
    Heinemann V; Labianca R; Hinke A; Louvet C
    Ann Oncol; 2007 Oct; 18(10):1652-9. PubMed ID: 17660491
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Meta-analysis of randomized trials: evaluation of benefit from gemcitabine-based combination chemotherapy applied in advanced pancreatic cancer.
    Heinemann V; Boeck S; Hinke A; Labianca R; Louvet C
    BMC Cancer; 2008 Mar; 8():82. PubMed ID: 18373843
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gemcitabine and platinum combinations in pancreatic cancer.
    Philip PA
    Cancer; 2002 Aug; 95(4 Suppl):908-11. PubMed ID: 12209670
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of gemcitabine plus platinum agents for biliary tract cancers: a meta-analysis.
    Yang R; Wang B; Chen YJ; Li HB; Hu JB; Zou SQ
    Anticancer Drugs; 2013 Sep; 24(8):871-7. PubMed ID: 23799294
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of advanced pancreatic cancer.
    Ducreux M; Boige V; Malka D
    Semin Oncol; 2007 Apr; 34(2 Suppl 1):S25-30. PubMed ID: 17449349
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gemcitabine-based cytotoxic doublets chemotherapy for advanced pancreatic cancer: updated subgroup meta-analyses of overall survival.
    Xie DR; Yang Q; Chen DL; Jiang ZM; Bi ZF; Ma W; Zhang YD
    Jpn J Clin Oncol; 2010 May; 40(5):432-41. PubMed ID: 20147334
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gemcitabine in the treatment of advanced pancreatic cancer: a comparative analysis of randomized trials.
    Heinemann V
    Semin Oncol; 2002 Dec; 29(6 Suppl 20):9-16. PubMed ID: 12577228
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gemcitabine-based combination treatment of pancreatic cancer.
    Heinemann V
    Semin Oncol; 2002 Feb; 29(1 Suppl 3):25-35. PubMed ID: 11894005
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Conventional chemotherapy of advanced pancreatic cancer.
    Giuliani F; Di Maio M; Colucci G; Perrone F
    Curr Drug Targets; 2012 Jun; 13(6):795-801. PubMed ID: 22458526
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recent updates on the role of chemotherapy in pancreatic cancer.
    Burris HA
    Semin Oncol; 2005 Aug; 32(4 Suppl 6):S1-3. PubMed ID: 16143160
    [TBL] [Abstract][Full Text] [Related]  

  • 13. What else in gemcitabine-pretreated advanced pancreatic cancer? An update of second line therapies.
    Petrelli F; Borgonovo K; Ghilardi M; Cabiddu M; Barni S
    Rev Recent Clin Trials; 2010 Jan; 5(1):43-56. PubMed ID: 20205687
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polychemotherapy or gemcitabine in advanced pancreatic cancer: a meta-analysis.
    Petrelli F; Coinu A; Borgonovo K; Cabiddu M; Ghilardi M; Barni S
    Dig Liver Dis; 2014 May; 46(5):452-9. PubMed ID: 24565950
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gemcitabine in Combination with a Second Cytotoxic Agent in the First-Line Treatment of Locally Advanced or Metastatic Pancreatic Cancer: a Systematic Review and Meta-Analysis.
    Zhang XW; Ma YX; Sun Y; Cao YB; Li Q; Xu CA
    Target Oncol; 2017 Jun; 12(3):309-321. PubMed ID: 28353074
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of gemcitabine plus platinum chemotherapy compared with other platinum containing regimens in advanced non-small-cell lung cancer: a meta-analysis of survival outcomes.
    Le Chevalier T; Scagliotti G; Natale R; Danson S; Rosell R; Stahel R; Thomas P; Rudd RM; Vansteenkiste J; Thatcher N; Manegold C; Pujol JL; van Zandwijk N; Gridelli C; van Meerbeeck JP; Crino L; Brown A; Fitzgerald P; Aristides M; Schiller JH
    Lung Cancer; 2005 Jan; 47(1):69-80. PubMed ID: 15603856
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The use of gemcitabine in non-small-cell lung cancer. Provincial Lung Cancer Disease Site Group. Provincial Systemic Treatment Disease Site Group.
    Evans WK; Kocha W; Gagliardi A; Eady A; Newman TE
    Cancer Prev Control; 1999 Feb; 3(1):84-94. PubMed ID: 10474757
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pancreatic cancer: is this bleak landscape finally changing? Highlights from the '43rd ASCO Annual Meeting'. Chicago, IL, USA. June 1-5, 2007.
    Saif MW
    JOP; 2007 Jul; 8(4):365-73. PubMed ID: 17625289
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytotoxic therapy for advanced pancreatic adenocarcinoma.
    O'Reilly EM; Abou-Alfa GK
    Semin Oncol; 2007 Aug; 34(4):347-53. PubMed ID: 17674963
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Docetaxel in the management of advanced pancreatic cancer.
    Lopes G; Rocha Lima CM
    Semin Oncol; 2005 Apr; 32(2 Suppl 4):S10-23. PubMed ID: 16015551
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.